Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials

BACKGROUND: Perinatal or mother-to-child transmission of hepatitis B virus (HBV) results in a high frequency of chronic infection. Risk of mother-to-child transmission is associated with maternal viral factors including hepatitis B e antigen (HBeAg) positivity and viral load.

AIM: To investigate associations between age, HBeAg status, HBV DNA levels and genotype in female patients screened for inclusion into two contemporary, randomized HBV trials.

METHODS: Retrospective analyses focused on differences between women of childbearing age (≤44 years) and older women. Female patients (N = 355; 18-69 years) were included in the analysis: 41.7% of patients were Asian. In total, 44.4% were HBeAg-positive.

RESULTS: Significantly more women aged ≤44 years were HBeAg-positive compared to women ≥45 years (57.2% versus 27.5%, respectively, p<0.0001), this proportion declined with increasing age. Younger women were significantly more likely to have high HBV viral load (HBV DNA>108 copies mL: ≤44 years 46.0% vs ≥45 years 25.5%, respectively; p<0.0001), and this declined with increasing age. HBeAg positivity was slightly higher in Asian women, associated with a higher proportion of HBV genotypes B and C in this population. There was no obvious relationship between genotype and viral load.

CONCLUSIONS: Women of childbearing age with CHB are more likely to have high HBV viral load and HBeAg positivity than older women; this likelihood decreases with age. Maternal serological and virological status should therefore be established early in pregnancy, taking into account age and genotype, and a risk-reducing strategy implemented in any patient who is HBeAg positive and has a high viral load.

Medienart:

E-Artikel

Erscheinungsjahr:

2015

Erschienen:

2015

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

PloS one - 10(2015), 3 vom: 21., Seite e0121632

Sprache:

Englisch

Beteiligte Personen:

Tran, Tram T [VerfasserIn]
Gordon, Stuart C [VerfasserIn]
Fung, Scott [VerfasserIn]
Dinh, Phillip [VerfasserIn]
Yee, Leland [VerfasserIn]
Martins, Eduardo Bruno [VerfasserIn]
Buti, Maria [VerfasserIn]
Marcellin, Patrick [VerfasserIn]

Links:

Volltext

Themen:

Antiviral Agents
DNA, Viral
Hepatitis B e Antigens
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 11.02.2016

Date Revised 16.03.2022

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0121632

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM247237647